Cargando…

Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study

BACKGROUND: Treatment decisions for any disease are usually informed by reference to published clinical guidelines or recommendations. These recommendations can be developed to improve the relative cost-effectiveness of health care and to reduce regional variation in clinical practice. Anti-tumor ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavan, Sean P., Daker-White, Gavin, Payne, Katherine, Barton, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921483/ https://www.ncbi.nlm.nih.gov/pubmed/31891115 http://dx.doi.org/10.1186/s41927-019-0097-0

Ejemplares similares

A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice
por: Jani, Meghna, et al.
Publicado: (2016)

Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol
por: Wright, Stuart, et al.
Publicado: (2018)

Generating evidence to inform health technology assessment of treatments for SLE: a systematic review of decision-analytic model-based economic evaluations
por: Gavan, Sean, et al.
Publicado: (2020)

Trouble with ataxia: A longitudinal qualitative study of the diagnosis and medical management of a group of rare, progressive neurological conditions
por: Daker-White, Gavin, et al.
Publicado: (2013)

Prescribing “placebo treatments”: results of national survey of US internists and rheumatologists
por: Tilburt, Jon C, et al.
Publicado: (2008)

Alopecia secondary to anti-tumor necrosis factor-alpha therapy()
por: Ribeiro, Lara Beatriz Prata, et al.
Publicado: (2015)

The care.data consensus? A qualitative analysis of opinions expressed on Twitter
por: Hays, Rebecca, et al.
Publicado: (2015)

Factors Influencing Prescribing Decisions of Physicians: A Review
por: Davari, Majid, et al.
Publicado: (2018)

Factors influencing rheumatologists’ prescription of biological treatment in rheumatoid arthritis: an interview study
por: Kalkan, Almina, et al.
Publicado: (2014)

Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
por: Pascual-Camps, Isabel, et al.
Publicado: (2014)

Paradoxical Side Effect Related With Anti-Tumor Necrosis Factor Alpha Treatment
por: Aşkın, Ayhan, et al.
Publicado: (2017)

Therapeutic monitoring of TNF inhibitors for rheumatoid arthritis: evidence required following NICE’s recommendations
por: Gavan, Sean P, et al.
Publicado: (2020)

Tumor Necrosis Factor Alpha Signaling and Organogenesis
por: You, Kai, et al.
Publicado: (2021)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

What moves the rheumatologist? Unravelling decision making in the referral of systemic sclerosis patients to health professionals: a qualitative study
por: Stöcker, Juliane K, et al.
Publicado: (2018)

GI Bleeding and Rheumatologists
por: Bossingham, D. H.
Publicado: (1992)

Induced myelopathy after long-term anti-tumor necrosis factor alpha treatment
por: Modesto, C, et al.
Publicado: (2011)

Anti-Tumor Necrosis Factor Alpha for Retinal Diseases: Current Knowledge and Future Concepts
por: Mirshahi, Alireza, et al.
Publicado: (2012)

Paradoxical Arthralgia Secondary to Anti-Tumor-Necrosis-Factor Alpha Therapy in Crohn’s Disease
por: Thurlapati, Aswani, et al.
Publicado: (2021)

Development and validation of a rheumatologist satisfaction with practice scale: The rheumatologist satisfaction scale
por: Sheth, Khushboo, et al.
Publicado: (2019)

Iatrogenic Kaposi Sarcoma Precipitated by Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-α) Therapy
por: Mariappan, Aathi Lakshmi, et al.
Publicado: (2021)

Opioid Prescribing for Osteoarthritis: Cross-Sectional Survey among Primary Care Physicians, Rheumatologists, and Orthopaedic Surgeons
por: Schnitzer, Thomas J., et al.
Publicado: (2023)

Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their children’s immunity
por: Lee, Ko Eun, et al.
Publicado: (2019)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
por: Morales-Torres, Jorge, et al.
Publicado: (2020)

AI am a rheumatologist: a practical primer to large language models for rheumatologists
por: Venerito, Vincenzo, et al.
Publicado: (2023)

A human inhibitor of tumor necrosis factor alpha
Publicado: (1988)

Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis
por: Callejas-Rubio, José Luis, et al.
Publicado: (2008)

TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH ALOPECIA AREATA
por: Kasumagic-Halilovic, Emina, et al.
Publicado: (2011)

Glaucomatous neurodegeneration: An eye on tumor necrosis factor-alpha
por: Agarwal, Renu, et al.
Publicado: (2012)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
por: Cavazzana, I, et al.
Publicado: (2005)

Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan
por: Hwang, De-Kuang, et al.
Publicado: (2018)

The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
por: Alourfi, Mansour, et al.
Publicado: (2020)

Treatment of Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease) With Anti-Tumor Necrosis Factor Alpha
por: Guerin, Clemence, et al.
Publicado: (2021)

Perspectives of patients, first-degree relatives and rheumatologists on preventive treatments for rheumatoid arthritis: a qualitative analysis
por: Munro, Sarah, et al.
Publicado: (2018)

Medicare beneficiary panel characteristics associated with high Part D biologic disease-modifying anti-rheumatic drug prescribing for older adults among rheumatologists
por: Lee, Jiha, et al.
Publicado: (2021)

Radionuclide synovectomy – essentials for rheumatologists
por: Chojnowski, Marek M., et al.
Publicado: (2016)

Rheumatologists’ perspective on hydroxychloroquine guidelines
por: Winebrake, James, et al.
Publicado: (2020)

Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: a qualitative descriptive study
por: Tomlinson, Emily J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fkt7d9g3e8b2l56qlckbj0ilk7